An aldol-based approach to the synthesis of the antibiotic anisomycin

Organic Letters

Volumn 4, Issue 2, 2002, Pages 265-267

  Hulme, Alison N ^a   Rosser, Edward M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3-HYDROXYBUTANAL; ALDEHYDE; ALDOL; ANISOMYCIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; GLYCOLIC ACID; GLYCOLIC ACID DERIVATIVE;

ARTICLE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ALDEHYDES; ANISOMYCIN; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; GLYCOLATES; STEREOISOMERISM;

EID: 0037165329     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol017016u     Document Type: Article

References (40)

1. Sobin, B. A.; Tanner, F. W., Jr. J. Am Chem. Soc. 1954, 76, 4053.
2. The Merck Index, 12th ed.; Windholz, M., Ed.; Merck: Whitehouse Station, NJ, 1996; p 710.
3. Hosoya, Y.; Kameyama, T.; Naganawa, H.; Okami, Y.; Takeuchi, T. J. Antibiot. 1993, 46, 1300.
4. (a) Van der Bosch, J.; Rueller, S.; Schlaak, M. German Patent DE 19,744,676, 1999; Chem. Abstr. 1999, 130, 291581.
5. (b) Rueller, S.; Stahl, C.; Kohler, G.; Eickhoff, B.; Breder, J.; Schlaak, M.; van der Bosch, J. Clin. Cancer Res. 1999, 5, 2714.
6. For a recent example of its use, see: (a) Dudai, Y. Nature 2000, 406, 686. (b) Nader, K.; Schafe, G. E.; Le Doux, J. E. Nature 2000, 406, 722.
7. For a recent example of its use, see: (a) Dudai, Y. Nature 2000, 406, 686. (b) Nader, K.; Schafe, G. E.; Le Doux, J. E. Nature 2000, 406, 722.
8. Törocsik, B.; Szeberényi, J. Eur. J. Neurosci. 2000, 12, 527 and references therein.
9. (a) Wong, C. M.; Bucchini, J.; Chang, I.; Te Raa, J.; Schenk, R. Can. J. Chem. 1969, 47, 2421.
10. (b) Oida, S.; Ohki, E. Chem. Pharm. Bull. 1969, 17, 1405.
11. (c) Felner, I.; Schenker, E. Helv. Chim. Acta 1970, 53, 754.
12. (d) Verheyden, J. P. H.; Richardson, A. C.; Bhatt, R. S.; Grant, B. D.; Flitch, W. L.; Moffat, J. G. Pure Appl. Chem. 1978, 50, 1363.
13. (e) Schumacher, D. P.; Hall, S. S. J. Am. Chem. Soc. 1982, 104, 6076.
14. (f) Buchanan, J. G.; MacLean, K. A.; Wightman, R. H.; Paulsen, H. J. Chem. Soc., Perkin Trans. 1 1985, 486.
15. (g) Iida, H.; Yamazaki, N.; Kibayashi, C. J. Org. Chem. 1986, 51, 1069.
16. (h) Meyers, A. I.; Dupre, B. Heterocycles 1987, 25, 113.
17. (i) Shono, T.; Kise, N. Chem. Lett. 1987, 697.
18. (j) Baer, H. H.; Zamkanei, M. J. Org. Chem. 1988, 53, 4786.
19. (k) Jegham, S.; Das, B. C. Tetrahedron Lett. 1988, 29, 4419.
20. (l) Takano, S.; Iwabuchi, Y.; Ogasawara, K. Heterocycles 1989, 29, 1861.
21. (m) Takahata, H.; Banba, Y.; Tajima, M.; Momose, T. J. Org. Chem. 1991, 56, 240.
22. (n) Ballini, R.; Marcantoni, E.; Petrini, M. J. Org. Chem. 1992, 57, 1316.
23. (o) Ikota, N. Heterocycles 1995, 41, 983.
24. (p) Yoda, H.; Nakajima, T.; Yamazaki, H.; Takabe, K. Heterocycles 1995, 41, 2423.
25. (q) Kang, S. H.; Choi, H.-W. Chem. Commun. 1996, 1521.
26. (r) Han, G.; LaPorte, M. G.; McIntosh, M. C.; Weinreb, S. M.; Parvez, M. J. Org. Chem. 1996, 61, 9483.
27. (s) Veith, U.; Schwardt, O.; Jaget, V. Synlett 1996, 1181.
28. (t) Huang, P. Q.; Wang, S. L.; Ruan, Y. P.; Gao, J. X. Nat. Prod. Lett. 1998, 11, 101.
29. (u) Shi, Z.-C.; Lin, G.-Q. Tetrahedron: Asymmetry 1995, 6, 2907.
30. (v) Delair, P.; Brot, E.; Kanazawa, A.; Greene, A. E. J. Org. Chem. 1999, 64, 1383.
31. (w) Schwartdt, O.; Veith, U.; Gaspard, C.; Jager, V. Synthesis 1999, 1473.
32. (x) Hutin, P.; Haddad, M.; Larcheveque, M. Tetrahedron: Asymmetry 2000, 11, 2547.
33. Hulme, A. N.; Montgomery, C. H.; Henderson, D. K. J. Chem. Soc., Perkin Trans. 1 2000, 1837.
34. For a recent review on the role of α-dibenzylamino aldehydes in synthesis, see: Reetz, M. T. Chem. Rev. 1999, 99, 1121.
35. 3 was shown to be of crucial importance in maintaining the stereochemical integrity of the α-amino ester.
36. A full analysis of the results of this and other related glycolate aldol reactions will be reported in a separate communication.
37. Fuhry, M. A. M.; Holmes, A. B.; Marshall, D. R. J. Chem Soc., Perkin Trans. 1 1993, 2743.
38. A synthetic route involving selective mono-N-debenzylation of the aldol adduct 7, cyclization to a protected pyrrolidin-2-one, and then reduction to the protected pyrrolidine 10 was not pursued, as in practice it was found to be most convenient to carry out the aldol coupling and reduction to alcohol 8 without purification of the intermediate aldol adduct 7.
39. The Evans oxazolidinone was also recovered in reasonable yield (60%).
40. Similar mesylate-induced cyclizations have been observed in the synthesis of N-(3-pyrrolodinylmethyl)benzamides: Thomas, C.; Hübner, H.; Gmeiner, P. Bioorg. Med. Chem. Lett. 1999, 9, 841.